Foster City, CA 9/7/07; New York, NY 9/7/07—-Applied Biosystems announced that the US District Court for the District of Connecticut granted its motion for summary judgment and dismissed all remaining claims in the patent infringement case brought by Enzo Biochem against Applera, Applied Biosystems’ parent company. In the lawsuit, filed in 2004, Enzo Biochem, Enzo […]
In July, Thermo Fisher Scientific announced the production of its 500th iCAP 6000 ICP emission spectrometer at its facility in Cambridge, UK. The product was shipped to Boeing.
Waltham, MA 9/5/07; Baltimore, MD 9/6/07—Thermo Fisher Scientific has acquired the instrument sales business of Davis Inotek Instruments, excluding its related calibration services. The business provides test, measurement and process control instruments through catalogs and e-commerce. It generated 2006 revenues of $30 million. Rebranded as Davis Instruments, the business will join Thermo Fisher’s Cole-Parmer customer […]
Chris van Ingen, president of Agilent’s Bio-Analytical Measurement unit, which is also known as Chemical Analysis and Life Sciences (LSCA), has spent close to 30 years working in the analytical instrument industry. On the occasion of the announcement of his retirement from Agilent at the end of Agilent’s fiscal year on October 31 (see IBO […]
GE Healthcare introduced illustra plasmidPrep Midi Flow and Mini Spin plasmid DNA purification kits, illustra blood genomicPrep Mini Spin and Midi Flow genomic DNA purification kits, and illustra GFX PCR DNA and Gel Band Purification kits. QIAGEN launched the QIAplex PCR multiplex assays, consisting of the ResPlex I, ResPlex II and StaphPlex Panels, which allow […]
Founded in 2001, the Canadian firm GenoLogics is based in Victoria, British Columbia, and develops laboratory information management systems (LIMS). The company’s first product was a LIMS for proteomics that grew out of a collaboration with the University of Victoria Genome BC Proteomics Center. As Tanis McSween, manager of marketing communications, explained, these collaborations gave […]
The European Food Safety Authority (EFSA) is examining new research that links food coloring and hyperactivity in children. The EFSA plans to review 45 colorings currently used in Europe by the end of 2008, and will rule on the coloring Allura Red later in the year. These reviews are based on the assessment of published […]
Stem cells have the ability to develop into almost any kind of cell. Spurred by stem cells’ potential to replace diseased cells and cure a wide variety of diseases, scientists around the globe have been studying the qualities of these cells. Because many different properties of stem cells still need to be understood, there are […]
March l’Etoile, France 9/11/07—BioMérieux has acquired BTF, a supplier of reference standards for microbiological testing and water control solutions. Financial details of the transaction were not disclosed. Based in Sydney, Australia, BTF generated 2006 sales of AUD 4 million ($3.0 million) and employs 24 people. “We are excited about the acquisition of BTF, our third […]
On September 10, the US government’s Interagency Working Group on Import Safety issued its first report on import safety. The Group, which includes personnel from 12 federal departments and agencies, was created in July by the Bush Administration following the discovery of tainted imported pet food (see IBO 5/31/07). The report recommends a strategic framework […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
